Vaccines
We live in a world where there are several micro-organisms and germs. These micro-organisms are so small that they are not visible to the naked eye. This includes micro-organisms like bacteria, viruses, fungus, protozoa, XXX. These can XXXXX XXXXXXXXXX in XXXXXX XXXXXXXXX which lead XX XXXXXXXX. XXXXX XXXX of XXX diseases take time XX recover, some diseases are XXXXXX. XXXXX XXXX XXXX many XXXX XXXXXXXX in XXX past which have caused deaths XX a large XXXXX XXXXX human XXXXXX. Vaccines XXX a XXX to XXXX XXX XXXXXXXX from their suffering XXX cure XXXX of the XXXXXXXX. XX is XXXXXXXX from the XXXXXXXX XXXX of the disease causing micro-organism XX treat the XXXXXXX XXX XXXXXX that XXX patient recovers XXXX. There is a XXX XX XXXXXXXX XXXX needs XX be undertaken for XXXXXXX XXX XXXX of any XXXXXXX. XXXX XXXXXXXX XXX XXXXXXXXX XX the XXXXX-organisms, symptoms XX the XXXXXXXX XXX. XXXXX-biology XX the XXXX XX XXXXXXX XXXX deals with the XXXXX XX micro-XXXXXXXXX XXX the XXX in XXXXX XXX XXXXX-XXXXXXXXX can XX XXXX XX XXXX a XXXX XX the XXXXXXX. The first XXXXXXX XXX developed by XXXXXX XXXXXX for the cure XX small XXX (XXXXXXXXX, 2009). After Jenner, XXXXXXX XXXXXXXXX XXX XXXX XX rabies XXXXXXX (Geison, 1995). A XXXXXXX is made XX of an XXXXX XXXX XX XXXXXXX XXXXXXX XX the XXXXXXX-XXXXXXX XXXXXXXXXXXXX. This contains XXX toxins XXX the surface proteins of the micro-organism. With XXX help of vaccines, XX have been able XX XXXXXXX XXXXXXXX XXXX polio, chicken pox, measles, XXXXX XXX. XXXXXXXXXX X, XX al. (XXXX) found in his study that the development of XXX vaccines XXXXXXX XXXXXXX other infectious XXXXXXXX XXXX XXXXXX or novel corona XXXXXXX XXXXXX XX XXXXXX XXXXX XXX already established XXXXXXXXXXXX but it is XXXXXXXX XXXX the efficiency of such vaccines will have XX XX XXXXXX XX the XXXXX-XXXXXXXXX XXXX complex XXXXXXXXXX and life-cycles. There is a XXXX challenge in XXX area of XXXXX-biology as the XXXXXXXX and XXXXXXXXXXX is XXXXXX and requires plenty XX XXXXXXXXX. XXXXXXXX have helped in public health programs XX XXXXXXX XXXXXXXX situations. X XXXXX number XX XXXXXXXX have been prevented with the help XX XXX vaccines developed XXXXXXX XXXXX-XXXXXXX. XXXX has XXXXX XXX XXXXX XX millions of XXXXXX. XXX recent outbreak of XXXXXX Virus (XXXXX-XX) XX XXXX being XXXXXXX because XX the research in XXXXX-biology which is leading to XXXXXXXXXXX the number XX deaths due XX this infection.
References:
Geison GL. 1995. XXX XXXXXXX science XX XXXXX XXXXXXX. Princeton, XX: XXXXXXXXX XXXXXXXXXX Press.
XXXXXXXXX DA. XXXX. Smallpox—XXX XXXXX of a disease. XXXXXXX, XX: XXXXXXXXXX Books.
Sabchareon A, XX al. XXXX. Protective efficacy XX XXX XXXXXXXXXXX, XXXX-attenuated, XXX XXXXXXXXXXX XXXXXX vaccine in XXXX XXXXXXXXXXXXXX: a XXXXXXXXXX, XXXXXXXXXX XXXXX XX tria . XXXXXX 380, XXXX–1567.
">